Design and validation of a new instrument to assess fear of falling in Parkinson's disease.


Journal

Movement disorders : official journal of the Movement Disorder Society
ISSN: 1531-8257
Titre abrégé: Mov Disord
Pays: United States
ID NLM: 8610688

Informations de publication

Date de publication:
10 2019
Historique:
received: 19 11 2018
revised: 03 07 2019
accepted: 16 07 2019
pubmed: 24 8 2019
medline: 13 6 2020
entrez: 24 8 2019
Statut: ppublish

Résumé

Fear of falling may be significantly associated with falls in Parkinson's disease (PD) and may have a negative impact on quality of life. Nevertheless, there are no valid and reliable tools to examine this condition in PD. The objective of this study was to design and determine the psychometric attributes of an instrument to assess fear of falling in PD. A prospective 1-year, 2-phase study was conducted to validate the Fear of Falling Scale, a self-assessed instrument for assessing fear of falling in PD. During phase 1, we designed a scale to measure the severity of fear of falling and determine its baseline psychometric characteristics, whereas phase 2 was a 1-year follow-up study to assess the frequency of falls and other clinical factors linked to fear of falling. Convergent and discriminant validity were assessed against the Fear of Falling Measure and the Starkstein Apathy Scale, respectively. The Fear of Falling Scale showed high internal consistency, test-retest reliability, and strong convergent and discriminant validity. There was a significant association between fear of falling score and the presence of both generalized anxiety disorder and major depression, poor balance-related motor ability, increased nonmotor symptoms of PD, more severe impairments in activities of daily living, and increased motor fluctuations. Finally, generalized anxiety disorder was a significant predictor of number of falls during a 12-month follow-up period. The Fear of Falling Scale is a valid and reliable instrument to assess fear of falling in PD. Fear of falling in PD is associated with specific psychiatric and motor disorders and is significantly related to the performance of balance-related motor functions. © 2019 International Parkinson and Movement Disorder Society.

Sections du résumé

BACKGROUND
Fear of falling may be significantly associated with falls in Parkinson's disease (PD) and may have a negative impact on quality of life. Nevertheless, there are no valid and reliable tools to examine this condition in PD. The objective of this study was to design and determine the psychometric attributes of an instrument to assess fear of falling in PD.
METHODS
A prospective 1-year, 2-phase study was conducted to validate the Fear of Falling Scale, a self-assessed instrument for assessing fear of falling in PD. During phase 1, we designed a scale to measure the severity of fear of falling and determine its baseline psychometric characteristics, whereas phase 2 was a 1-year follow-up study to assess the frequency of falls and other clinical factors linked to fear of falling. Convergent and discriminant validity were assessed against the Fear of Falling Measure and the Starkstein Apathy Scale, respectively.
RESULTS
The Fear of Falling Scale showed high internal consistency, test-retest reliability, and strong convergent and discriminant validity. There was a significant association between fear of falling score and the presence of both generalized anxiety disorder and major depression, poor balance-related motor ability, increased nonmotor symptoms of PD, more severe impairments in activities of daily living, and increased motor fluctuations. Finally, generalized anxiety disorder was a significant predictor of number of falls during a 12-month follow-up period.
CONCLUSIONS
The Fear of Falling Scale is a valid and reliable instrument to assess fear of falling in PD. Fear of falling in PD is associated with specific psychiatric and motor disorders and is significantly related to the performance of balance-related motor functions. © 2019 International Parkinson and Movement Disorder Society.

Identifiants

pubmed: 31442364
doi: 10.1002/mds.27820
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1496-1504

Informations de copyright

© 2019 International Parkinson and Movement Disorder Society.

Références

Tinetti ME, Powell L. Fear of falling and low self-efficacy: a case of dependence in elderly persons. J Gerontol 1993;48:35-38.
Jørstad EC, Hauer K, Becker C, Lamb SE. Measuring the psychological outcomes of falling: A systematic review. J Am Geriatr Soc 2005;53(3):501-510.
Nilsson MH, Drake AM, Hagell P. Assessment of fall-related self-efficacy and activity avoidance in people with Parkinson's disease. BMC Geriatr 2010;10:78
Friedman SM, Munoz B, West SK, Rubin GS, Fried LP. Falls and fear of falling: which comes first? A longitudinal prediction model suggests strategies for primary and secondary prevention. J Am Geriatr Soc 2002;50:1329-1335.
Franchignoni F, Martignoni E, Ferriero G, Pasetti C. Balance and fear of falling in Parkinson's disease. Park Relat Disord 2005;11(7):427-433.
Cumming RG, Salkeld G, Thomas M, Szonyi G. Prospective Study of the Impact of Fear of Falling on Activities of Daily Living, SF-36 Scores, and Nursing Home Admission. J Gerontol Med Sci Am 2000;55(5):299-305.
Lord S, Galna B, Yarnall AJ, et al. Natural history of falls in an incident cohort of Parkinson's disease: early evolution, risk and protective features. J Neurol. 2017;264(11):2268-2276.
Tinetti ME, Mendes de Leon CF, Doucette JT, Baker DI. Fear of falling and fall-related efficacy in relationship to functioning among community-living elders. J Gerontol 1994;49(3):M140-147.
Myers AM, Powell LE, Maki BE, Holliday PJ, Brawley LR, Sherk W. Psychological indicators of balance confidence: relationship to actual and perceived abilities. J Gerontol A Biol Sci Med Sci 1996;51(1):M37-M43.
Hadjistavropoulos T, Martin RR, Sharpe D, Lints AC, McCreary DR, Asmundson GJG. A longitudinal investigation of fear of falling, fear of pain, and activity avoidance in community-dwelling older adults. J Aging Health 2007;19(6):965-984.
Guo JL, Tsai YY, Liao JY, Tu HM, Huang CM. Interventions to reduce the number of falls among older adults with/without cognitive impairment: An exploratory meta-analysis. Int J Geriatr Psychiatry 2014;29(7):661-669.
Hadjistavropoulos T, Delbaere K, Fitzgerald TD. Reconceptualizing the role of fear of falling and balance confidence in fall risk. J Aging Health 2011;23(1):3-23.
Yardley L, Beyer N, Hauer K, Kempen G, Piot-Ziegler C, Todd C. Development and initial validation of the Falls Efficacy Scale-International (FES-I). Age Ageing 2005;34:614-619.
Velozo CA, Peterson EW. Developing meaningful fear of falling measures for community dwelling elderly. Am J Phys Med Rehabil 2001;80(9):662-673.
Powell LE, Myers AM. The Activities-specific Balance Confidence (ABC) Scale. J Gerontol Med Sci 1995;50:28-34.
Lachman ME, Howland J, Tennstedt S, Jette A, Assmann S, Peterson EW. Fear of falling and activity restriction: the survey of activities and fear of falling in the elderly (SAFE). J Gerontol B Psychol Sci Soc Sci 1998;53(1):P43-P50.
Stolze H, Klebe S, Zechlin C, Baecker C, Friege L, Deuschl G. Falls in frequent neurological diseases: Prevalence, risk factors and aetiology. J Neurol 2004;251(1):79-84.
Balash Y, Peretz C, Leibovich G, Herman T, Hausdorff JM, Giladi N. Falls in outpatients with Parkinson's disease: frequency, impact and identifying factors. J Neurol 2005;252:1310-1315.
Pickering RM, Grimbergen YA, Rigney U, et al. A Meta-Analysis of Six Prospective Studies of Falling in Parkinson's Disease. Mov Disord 2007;22(13):1892-1900.
Allen NE, Schwarzel AK, Canning CG. Recurrent falls in Parkinson's disease: a systematic review. Parkinsons Dis 2013; doi: https://doi.org/10.1155/2013/906274.
Mak MKY, Pang MYC. Parkinsonian single fallers versus recurrent fallers: Different fall characteristics and clinical features. J Neurol 2010;257:1543-1551.
Fasano A, Canning CG, Hausdorff JM, Lord S, Rochester L. Falls in Parkinson's disease: A complex and evolving picture. Mov Disord 2017;32(11):1524-1536.
Starkstein S, Dragovic M, Brockman S, Wilson M, Bruno V, Merello M. The Impact of Emotional Distress on Motor Blocks and Festination in Parkinson's Disease. J Neuropsychiatry Clin Neurosci 2015;27(2):121-126.
Millar Vernetti P, Perez Lloret S, Rossi M, Cerquetti D MM. Validation of a new scale to assess olfactory dysfunction in patients with Parkinson's disease. Park Relat Disord 2012;18(4):358-361.
Starkstein SE, Merello M, Jorge R, Brockman S, Bruce D PB. The syndromal validity and nosological position of apathy in Parkinson's disease. Mov Disord 2009;24(8):1211-1216.
Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55(3):181-184.
Dilip Jeste P V, Jeffrey Lieberman P-EA, David Fassler T, et al. Diagnostic and Statistical Manual of Mental Disorders, 5th ed. DSM-5. 2012; 947 p.
Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Mov Disord 2008;23(15):2129-2170.
Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12(3):189-198.
Sheehan D V, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(Suppl 20):22-33 quiz 34-57.
Starkstein SE, Migliorelli R, Manes F, et al. The prevalence and clinical correlates of apathy and irritability in Alzheimer's disease. Eur J Neurol 1995;2:540-546.
Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010;25(15):2649-2653.
Gibson M, Andres R, Isaacs B W-PJ. “The prevention of falls in later life. A report of the Kellogg International Work Group on the Prevention of Falls by the Elderly.” Dan Med Bull 1987;34(S4):1-24.
Schober P, Boer C, Schwarte LA. Correlation Coefficients: Appropriate Use and Interpretation. Anesth Analg 2018;126 (5):1763-1768
Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires.J Clin Epidemiol 2007;60:34-42.
Lindholm B, Hagell P, Hansson O, Nilsson MH. Factors associated with fear of falling in people with Parkinson's disease. BMC Neurol 2014;14:19.
Bhala RP, O'Donnell J, Thoppil E. Ptophobia. Phobic fear of falling and its clinical management. Phys Ther 1982;62(2):187-190.
Gai J, Gomes L, Jansen De Cárdenas C. Ptofobia: O medo de cair em pessoas idosas. Acta Med Port 2009;22(1):83-88.
Yardley L, Smith H. A prospective study of the relationship betweeneFeared consequences of falling and avoidance of activity in community-living older people. Gerontologist 2002;42(1):17-23.
Broen MP, Narayen NE, Kuijf ML, Dissanayaka NN, Leentjens AF. Prevalence of anxiety in Parkinson's disease: A systematic review and meta-analysis. Mov Disord 2016;31(8):1125-1133.
Trollor JN, Anderson TM, Sachdev PS, Brodaty H, Andrews G. Prevalence of Mental Disorders in the Elderly: The Australian National Mental Health and Well-Being Survey. Am J Geriatr Psychiatry 2007;15(6):455-466.
Payette MC, Bélanger C, Benyebdri F, et al. The Association between Generalized Anxiety Disorder, Subthreshold Anxiety Symptoms and Fear of Falling among Older Adults: Preliminary Results from a Pilot Study. Clin Gerontol 2017;40(3):197-206.

Auteurs

Cinthia Terroba-Chambi (C)

Raul Carrea Institute of Neurological Research, Movement Disorders Unit, FLENI, Buenos Aires, Argentina.

Veronica Bruno (V)

Department of Neurosciences, University of Calgary, Calgary, Alberta, Canada.

Patricio Millar-Vernetti (P)

Raul Carrea Institute of Neurological Research, Movement Disorders Unit, FLENI, Buenos Aires, Argentina.

David Bruce (D)

School of Psychiatry and Clinical Neurosciences, Fremantle, Western Australia, Australia.
School of Medicine and Pharmacology, University of Western Australia, Fremantle, Western Australia, Australia.

Simone Brockman (S)

School of Psychiatry and Clinical Neurosciences, Fremantle, Western Australia, Australia.

Marcelo Merello (M)

Raul Carrea Institute of Neurological Research, Movement Disorders Unit, FLENI, Buenos Aires, Argentina.
National Scientific and Technological Research Council (CONICET), Buenos Aires, Argentina.

Sergio Starkstein (S)

School of Psychiatry and Clinical Neurosciences, Fremantle, Western Australia, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH